New Electrode for Prosthetic Limb Control in Amputees
Trial Summary
What is the purpose of this trial?
The device, a bipolar percutaneous intramuscular electromyography electrode, is intended for use in upper-limb amputation patients who have received the regenerative peripheral nerve interface surgical procedure, in order to enable the use of advanced prosthetic arms and hands.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have an autoimmune condition, it must be well controlled by medication to participate.
What data supports the effectiveness of the treatment Bipolar Percutaneous Intramuscular Electromyography Electrode for prosthetic limb control in amputees?
Research shows that intramuscular electrodes, like the ones used in this treatment, can effectively record muscle signals for controlling prosthetic limbs, as they provide better signal fidelity compared to other types of electrodes. Additionally, studies have demonstrated the long-term stability and performance of similar electrode systems in human participants, suggesting their potential effectiveness in improving prosthetic control.12345
Is the new electrode for prosthetic limb control safe for humans?
How is the new electrode treatment for prosthetic limb control different from other treatments?
The new electrode treatment for prosthetic limb control is unique because it uses a fully implanted intramuscular bipolar myoelectric signal recording electrode, which allows for more precise and stable control of prosthetic limbs by capturing muscle signals directly from within the muscles. This approach differs from traditional methods that rely on surface electrodes or external devices, offering potentially improved long-term performance and functionality for amputees.12389
Eligibility Criteria
This trial is for adults over 22 with an upper-limb amputation who are in good health and low surgical risk. They must have reliable transport, attend at least two visits per month, not use tobacco, and cannot be pregnant or have severe mental health issues without approval.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Recovery
Participants undergo surgery to implant RPNI grafts and electrodes, followed by a recovery period
Prosthetic Control and Sensory Feedback Experiments
Experiments with prosthetic control and sensory feedback are conducted
Follow-up
Participants are monitored for safety and effectiveness after electrode explantation
Treatment Details
Interventions
- Bipolar Percutaneous Intramuscular Electromyography Electrode
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator